Table 2.
Items | D1 | D2 | D3 | D4 | D5 |
---|---|---|---|---|---|
Control | Oxidized Fish Oil (OFO) | OFO + AX150 | OFO + AX250 | OFO + AX450 | |
Hemolymph malondialdehyde (MDA) (mmol L−1) |
4.40 ± 0.40 a | 6.76 ± 0.75 b | 4.78 ± 0.29 a,b | 5.22 ± 0.22 a,b | 6.01 ± 0.36 a,b |
Hemolymph catalase (CAT) (U L−1) |
1.07 ± 0.06 b,c | 0.54 ± 0.26 a | 0.90 ± 0.19 a,b | 1.17 ± 0.14 b,c | 1.50 ± 0.13 c |
Hepatopancreas MDA (nmol mg−1prot ) |
1.96 ± 0.50 | 3.32 ± 1.10 | 3.06 ± 0.81 | 2.11 ± 0.15 | 1.97 ± 0.12 |
Hepatopancreas iNOS (U mg−1prot) |
1.35 ± 0.11 a,b | 1.28 ± 0.09 a | 1.39 ± 0.10 a,b | 1.54 ± 0.15 a,b | 1.62 ± 0.10 b |
a,b,c Mean values within a row without a common superscript letter were significantly different (p ≤ 0.05). Data represent mean ± SEM of four replicates.